We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.21B
AUM Growth
+$243M
Cap. Flow
+$12.7M
Cap. Flow %
0.3%
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$20.5M
2
NFLX icon
Netflix
NFLX
+$19.9M
3
COST icon
Costco
COST
+$18.6M
4
IBM icon
IBM
IBM
+$17.9M
5
PLTR icon
Palantir
PLTR
+$17.5M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$19.1M
2
QCOM icon
Qualcomm
QCOM
+$19.1M
3
CMCSA icon
Comcast
CMCSA
+$19.1M
4
INTC icon
Intel
INTC
+$19.1M
5
UPS icon
United Parcel Service
UPS
+$19M

Sector Composition

Rank Sector Weight
1 Financials 28.41%
2 Consumer Discretionary 12.52%
3 Industrials 11.69%
4 Technology 11.49%
5 Energy 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
876
CytomX Therapeutics
CTMX
$723M
$286K 0.01%
126,000
-180,624
-59% -$291K
UTMD icon
877
Utah Medical Products
UTMD
$227M
$285K 0.01%
5,000
– –
SSBK
878
DELISTED
Southern States Bancshares
SSBK
$284K 0.01%
7,807
-51,515
-87% -$1.76M
BGFV
879
DELISTED
Big 5 Sporting Goods
BGFV
$283K 0.01%
199,251
-77,408
-28% -$83K
SAMG icon
880
Silvercrest Asset Management
SAMG
$79.2M
$281K 0.01%
17,702
– –
PLX icon
881
Protalix BioTherapeutics
PLX
$197M
$280K 0.01%
189,100
– –
CADL icon
882
Candel Therapeutics
CADL
$766M
$279K 0.01%
+55,100
New +$284K
SPWR icon
883
SunPower Inc
SPWR
$53.8M
$277K 0.01%
150,600
+6,400
+4% +$11.1K
ASMB icon
884
Assembly Biosciences
ASMB
$526M
$276K 0.01%
15,225
– –
GTIM icon
885
Good Times Restaurants
GTIM
$14.8M
$275K 0.01%
153,813
+6,975
+5% +$12.7K
III icon
886
Information Services Group
III
$204M
$275K 0.01%
57,200
– –
STC icon
887
Stewart Information Services
STC
$2.08B
$274K 0.01%
4,214
-51,850
-92% -$3.33M
CLAR icon
888
Clarus
CLAR
$129M
$274K 0.01%
79,017
-46,869
-37% -$159K
TRMK icon
889
Trustmark
TRMK
$2.83B
$273K 0.01%
7,500
– –
MXCT icon
890
MaxCyte
MXCT
$115M
$273K 0.01%
+125,000
New +$303K
ATLO icon
891
AMES National
ATLO
$277M
$272K 0.01%
15,273
+536
+4% +$9.32K
SNBR
892
DELISTED
Sleep Number
SNBR
$271K 0.01%
40,100
+5,500
+16% +$42K
MTEX icon
893
Mannatech
MTEX
$9.78M
$271K 0.01%
28,954
-1,241
-4% -$12.2K
CRVS icon
894
Corvus Pharmaceuticals
CRVS
$1.17B
$267K 0.01%
66,700
+25,400
+62% +$92.4K
MPTI icon
895
M-tron Industries
MPTI
$377M
$266K 0.01%
6,334
– –
BKTI icon
896
BK Technologies
BKTI
$292M
$266K 0.01%
5,644
– –
MCBS icon
897
MetroCity Bankshares
MCBS
$1.03B
$266K 0.01%
9,291
– –
NWFL icon
898
Norwood Financial Corp
NWFL
$371M
$265K 0.01%
10,276
-6,733
-40% -$169K
EDIT icon
899
Editas Medicine
EDIT
$422M
$264K 0.01%
120,000
+100,000
+500% +$164K
DTIL icon
900
Precision BioSciences
DTIL
$193M
$260K 0.01%
+61,901
New +$305K
34 35
36
37 38

Similar funds

CFC
Cincinnati Financial Corp Fairfield, Ohio $4.96B AUM 18.21% 1-Year Est. Return
SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Bridgeway Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
  • Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
  • Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
  • Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
  • Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
  • Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
  • Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.

Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.